Showing 1 - 3 results of 3 for search 'Barbara Sinigaglia', query time: 0.03s
Refine Results
-
1
Polo-like kinase-1, Aurora kinase A and WEE1 kinase are promising druggable targets in CML cells displaying BCR::ABL1-independent resistance to tyrosine kinase inhibitors by Manuela Mancini, Sara De Santis, Cecilia Monaldi, Fausto Castagnetti, Fausto Castagnetti, Annalisa Lonetti, Samantha Bruno, Elisa Dan, Barbara Sinigaglia, Barbara Sinigaglia, Gianantonio Rosti, Michele Cavo, Michele Cavo, Gabriele Gugliotta, Simona Soverini
Published 2022-08-01
Article -
2
Case report: Senescence as mechanism of resistance to Pembrolizumab in a Lymphoma patient who failed CD19-Targeted CAR-T cell therapy by Serena De Matteis, Beatrice Casadei, Beatrice Casadei, Ginevra Lolli, Ginevra Lolli, Michele Dicataldo, Michele Dicataldo, Francesco Barbato, Francesco Barbato, Elisa Dan, Andrea Paccagnella, Barbara Sinigaglia, Clara Bertuzzi, Annalisa Arcari, Luca Zazzeroni, Patrizia Bernuzzi, Noemi Laprovitera, Gianluca Storci, Salvatore Nicola Bertuccio, Manuela Ferracin, Massimiliano Bonafè, Pier Luigi Zinzani, Pier Luigi Zinzani, Francesca Bonifazi
Published 2022-10-01
Article -
3
Peripheral blood cellular profile at pre-lymphodepletion is associated with CD19-targeted CAR-T cell-associated neurotoxicity by Serena De Matteis, Michele Dicataldo, Michele Dicataldo, Beatrice Casadei, Beatrice Casadei, Gianluca Storci, Noemi Laprovitera, Mario Arpinati, Enrico Maffini, Pietro Cortelli, Pietro Cortelli, Maria Guarino, Francesca Vaglio, Maria Naddeo, Maria Naddeo, Barbara Sinigaglia, Luca Zazzeroni, Serafina Guadagnuolo, Enrica Tomassini, Salvatore Nicola Bertuccio, Daria Messelodi, Manuela Ferracin, Massimiliano Bonafè, Pier Luigi Zinzani, Pier Luigi Zinzani, Francesca Bonifazi
Published 2023-01-01
Article